Genemarkers Sponsors Rare Disease Challenge
News May 02, 2013
Genemarkers will be providing Genomics Expression Analysis for Silveira’s research on Chronic Beryllium Disease (CBD). Silveira was selected out of 77 applicants covering 67 types of rare disease.
"We are thrilled to be part of the Rare Disease Challenge and to have the opportunity to assist Lori Silveira,” says Dr. Anna Langerveld, president and CEO of Genemarkers. “We are proud that our team of experienced genomics scientists can assist in advancing this research.”
Genemarkers joins 19 other companies as service donors for the competition, hosted by Assay Depot and Rare Genomics Institute. Rare Genomic Institute’s expert panel and a Genemarkers technical expert selected winners for the service donation. The total value of all services reached $500,000, which will go towards helping accelerate rare disease research. To view all service winners and company donations, please visit http://challenge.assaydepot.com/rare-disease-awards.
The competition also features a $10,000 prize with the winner being chosen by Facebook voting. The community can participate by voting for their favorite research proposals on Facebook at http://www.facebook.com/raregenomics.
Genemarkers will work with Lori Silveira over the next few months and push Chronic Beryllium Disease (CBD) research to a new level.
Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories ForwardNews
First nanotechnological approach enables the design and replication of complex single-stranded DNA and RNA origami with potential for drug delivery and nanofabrication.READ MORE
Cracking the Code of Coenzyme Q BiosynthesisNews
Coenzyme Q is a vital cog in the body’s energy-producing machinery, a kind of chemical gateway in the conversion of food into cellular fuel. Researchers are developing new tools to shed light on CoQ function, primarily by finding and defining proteins that have a direct link to the chemical. This includes the development of a new multi-omic strategy to identify the global function of an RNA-binding protein that has long been associated with mitochondria and its role in CoQ biosynthesis.READ MORE
First Successful Gene Therapy Trial Reported for People with Hemophilia ANews
Patients with hemophilia A who received a single infusion of an investigational gene therapy showed improved levels of the essential blood clotting protein FVIII, with 11 of 13 achieving normal or near-normal FVIII levels.READ MORE